title: The Value of Admission Serum IL-8 Monitoring and the Correlation with IL-8 (-251A/T) Polymorphism in Critically Ill Patients.
abstract: Background. The clinical management of sepsis is a highly complicated process. Disruption of the immune system explains in part the major variation in sepsis outcome. IL-8 is a proinflammatory cytokine, genetic polymorphism of this cytokine could explain the outcome of sepsis. The present study was conducted to determine the value of serum IL-8 monitoring and its (-251A/T) genetic polymorphism in critically ill patients. Patients and Methods. 180 critically ill patients were allocated into two groups, 90 septic patients (sepsis group) and 90 nonseptic patients (SIRS group). Admission serum IL-8 and its (-251A/T) mutant allele were detected. Results. The admission mean value of serum IL-8 was significantly elevated in sepsis group. In both groups, the mean value of serum IL-8 in nonsurvived patients and patients with IL-8 (-251A/T) mutant allele was significantly higher. A positive correlation of survival and IL-8 (-251A/T) mutant allele was detected in both groups. The serum IL-8 distinguished wild from IL-8 (-251A/T) mutant allele at a cut-off value of 600 pg/mL. Conclusion. The admission mean value of serum IL-8 was significantly elevated in septic, nonsurvived, and patients with IL-8 (-251A/T) mutant alleles. A positive correlation of survival and IL-8 (-251A/T) mutant allele patients was detected.
authors.affiliation: Faculty of Medicine, Tanta University, Tanta, Egypt.
authors.forename: Ayman Abd Al-Maksoud
authors.initials: AA
authors.lastname: Yousef
authors.affiliation: Faculty of Medicine, Tanta University, Tanta, Egypt.
authors.forename: Ghada Abdulmomen
authors.initials: GA
authors.lastname: Suliman
authors.affiliation: Faculty of Medicine, Tanta University, Tanta, Egypt.
authors.forename: Maaly Mohamed
authors.initials: MM
authors.lastname: Mabrouk
references.citation: Clin Exp Immunol. 2002 Feb;127(2):331-6
references.pmid: 11876758
references.citation: Infect Immun. 1992 Jul;60(7):2835-42
references.pmid: 1612748
references.citation: Am J Respir Crit Care Med. 2008 Aug 1;178(3):276-82
references.pmid: 18511707
references.citation: Clin Infect Dis. 2005 Nov 15;41 Suppl 7:S396-402
references.pmid: 16237637
references.citation: Br J Anaesth. 1996 Jul;77(1):110-7
references.pmid: 8703620
references.citation: Physiol Genomics. 2007 Jul 18;30(2):146-55
references.pmid: 17374846
references.citation: Am J Respir Crit Care Med. 2003 Aug 15;168(4):476-80
references.pmid: 12746253
references.citation: N Engl J Med. 1988 Mar 24;318(12):727-32
references.pmid: 3347221
references.citation: Am J Med. 2001 Apr 15;110(6):486-8
references.pmid: 11331061
references.citation: Pediatr Crit Care Med. 2005 May;6(3 Suppl):S61-73
references.pmid: 15857562
references.citation: Minerva Anestesiol. 2006 May;72(5):255-67
references.pmid: 16675935
references.citation: Infect Immun. 1994 Mar;62(3):943-7
references.pmid: 8112867
references.citation: Crit Care Med. 1996 Sep;24(9):1448-54
references.pmid: 8797614
references.citation: Haemostasis. 1997 Mar-Apr;27(2):51-6
references.pmid: 9212352
references.citation: Thorax. 2000 Dec;55(12):1023-7
references.pmid: 11083887
references.citation: Infect Immun. 1996 Nov;64(11):4733-8
references.pmid: 8890233
references.citation: Crit Care. 2009;13(3):141
references.pmid: 19490589
references.citation: Crit Care Med. 1992 Jun;20(6):864-74
references.pmid: 1597042
references.citation: Clin Diagn Lab Immunol. 2002 Nov;9(6):1205-11
references.pmid: 12414751
references.citation: BMC Med. 2006 Apr 12;4:10
references.pmid: 16611358
references.citation: Crit Care Med. 1994 Apr;22(4):673-9
references.pmid: 8143477
references.citation: Am J Respir Crit Care Med. 2008 Oct 1;178(7):710-20
references.pmid: 18635889